1. |
Smith JS, Shaffrey CI, Ames CP, et al. Treatment of adult thoracolumbar spinal deformity: past, present, and future. J Neurosurg Spine, 2019, 30(5): 551-567.
|
2. |
Katsuura Y, Osborn JM, Cason GW. The epidemiology of thoracolumbar trauma: a meta-analysis. J Orthop, 2016, 13(4): 383-388.
|
3. |
Kato S, Murray JC, Kwon BK, et al. Does surgical intervention or timing of surgery have an effect on neurological recovery in the setting of a thoracolumbar burst fracture?. J Orthop Trauma, 2017, 31(Suppl 4): S38-S43.
|
4. |
Wood KB, Li W, Lebl DR, et al. Management of thoracolumbar spine fractures. Spine J, 2014, 14(1): 145-164.
|
5. |
Shin SR, Lee SS, Kim JH, et al. Thoracolumbar burst fractures in patients with neurological deficit: anterior approach versus posterior percutaneous fixation with laminotomy. J Clin Neurosci, 2020, 75(75): 11-18.
|
6. |
Kirkpatrick JS. Thoracolumbar fracture management: anterior approach. J Am Acad Orthop Surg, 2003, 11(5): 355-363.
|
7. |
Taam J, Qj Y, Pang KS, et al. Current evidence and future directions of tranexamic acid use, efficacy, and dosing for major surgical procedures. J Cardiothorac Vasc Anesth, 2020, 34(3): 782-790.
|
8. |
Xiong H, Liu Y, Zeng Y, et al. The efficacy and safety of combined administration of intravenous and topical tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled trials. BMC Musculoskelet Disord, 2018, 19(1): 321.
|
9. |
Leff J, Rhee A, Nair S, et al. A randomized, double-blinded trial comparing the effectiveness of tranexamic acid and epsilon-aminocaproic acid in reducing bleeding and transfusion in cardiac surgery. Ann Card Anaesth, 2019, 22(3): 265-272.
|
10. |
Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery, 1962, 51(2): 224-232.
|
11. |
Rosenthal BD, Boody BS, Jenkins TJ, et al. Thoracolumbar burst fractures. Clin Spine Surg, 2018, 31(4): 143-151.
|
12. |
Morrissey PB, Shafi KA, Wagner SC, et al. Surgical management of thoracolumbar burst fractures: surgical decision-making using the AOSpine thoracolumbar injury classification score and thoracolumbar injury classification and severity score. Clin Spine Surg, 2020.
|
13. |
Piccone L, Cipolloni V, Nasto LA, et al. Thoracolumbar burst fractures associated with incomplete neurological deficit in patients under the age of 40: is the posterior approach enough? Surgical treatment and results in a case series of 10 patients with a minimum follow-up of 2 years. Injury, 2020, 51(2): 312-316.
|
14. |
Tan T, Huang MS, Mathew J, et al. Anterior versus posterior approach in the management of AO Type B1 & B2 traumatic thoracolumbar fractures: a level 1 trauma centre study. J Clin Neurosci, 2020, 72(72): 219-223.
|
15. |
Lin Y, Cohen R, Armali C, et al. Transfusion-associated circulatory overload prevention: a retrospective observational study of diuretic use. Vox Sang, 2018, 113(4): 386-392.
|
16. |
Roubinian NH, Triulzi DJ. Transfusion-associated circulatory overload and transfusion-related acute lung injury: etiology and prevention. Hematol Oncol Clin North Am, 2019, 33(5): 767-779.
|
17. |
Hunt BJ. The current place of tranexamic acid in the management of bleeding. Anaesthesia, 2015, 70(Suppl 1): 50-53, e18.
|
18. |
Pong RP, Leveque JA, Edwards A, et al. Effect of tranexamic acid on blood loss, D-Dimer, and fibrinogen kinetics in adult spinal deformity surgery. J Bone Joint Surg Am, 2018, 100(9): 758-764.
|
19. |
Guo J, Gao X, Ma Y, et al. Different dose regimes and administration methods of tranexamic acid in cardiac surgery: a meta-analysis of randomized trials. BMC Anesthesiol, 2019, 19(1): 129.
|
20. |
Fillingham YA, Ramkumar DB, Jevsevar DS, et al. The efficacy of tranexamic acid in total knee arthroplasty: a network meta-analysis. J Arthroplasty, 2018, 33(10): 3090-3098.
|
21. |
Goobie SM, Zurakowski D, Glotzbecker MP, et al. Tranexamic acid is efficacious at decreasing the rate of blood loss in adolescent scoliosis surgery: a randomized placebo-controlled trial. J Bone Joint Surg Am, 2018, 100(23): 2024-2032.
|
22. |
Du Y, Feng CC. The efficacy of tranexamic acid on blood loss from lumbar spinal fusion surgery: a meta-analysis of randomized controlled trials. World Neurosurg, 2018, 119(119): e228-e234.
|
23. |
Mcleod LM, French B, Flynn JM, et al. Antifibrinolytic use and blood transfusions in pediatric scoliosis surgeries performed at US children’s hospitals. J Spinal Disord Tech, 2015, 28(8): E460-E466.
|
24. |
Yee BE, Wissler RN, Zanghi CN, et al. The effective concentration of tranexamic acid for inhibition of fibrinolysis in neonatal plasma in vitro. Anesth Analg, 2013, 117(4): 767-772.
|
25. |
Kim KT, Kim CK, Kim YC, et al. The effectiveness of low-dose and high-dose tranexamic acid in posterior lumbar interbody fusion: a double-blinded, placebo-controlled randomized study. Eur Spine J, 2017, 26(11): 2851-2857.
|
26. |
Johnson DJ, Johnson CC, Goobie SM, et al. High-dose versus low-dose tranexamic acid to reduce transfusion requirements in pediatric scoliosis surgery. J Pediatr Orthop, 2017, 37(8): e552-e557.
|
27. |
HALT-IT Trial Collaborators. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. Lancet, 2020, 395(10241): 1927-1936.
|